Webinar: Systemic treatment of differentiated thyroid cancer – key to success with a thyrosine kinase inhibitor (TKI)
Target group: Health care providers
The expected audience for this webinar are oncologists, endocrinologists, nuclear medicine physicians, surgeons and internal medicine physicians.
16.00-16.45 What is special in metastatic or locally advanced thyroid cancer? - Adjunct Prof. Hanna Mäenpää │ Comprehensive Cancer Center of Helsinky University, Finland
16.45-17.15 Optimization of lenvatinib treatment in radioiodine refractory differentiated thyroid cancer - Prof. Emese Mezősi │ University of Pécs, Hungary
Case studies presentations by specialties DTC patients meet in their patient journey:
17:15 Advanced DTC in initially low-risk patient - a case presentation- Dr. Eve Kelk (East-Tallinn Central Hospital, Estonia)
17:25 Case study II - Dr. Skaistė Tulytė (Vilnius University Hospital Santaros Klinikos, Lithuania)
17:35 Case study III - Dr. Ilona Muoni (North-Estonian Regional Hospital, Estonia)
17:45 Q & A
Registration: Participating in the webinar is free. To register, please fill in the online registration form down below (participating is free, but you should also fill in payer information to finish the registration). For questions and additional information please contact us via e-mail email@example.com
NB! Webinar takes place in the Zoom platform. Detailed information and instructions on how to participate will be sent to the participants' e-mail a day before the event (just in case, check your spam folder). Please include your personal email address on the registration form.
Registration ends on 25.01.2021 at 17.00.
Please fill in the form below to register! The invoice will be sent after registration to your e-mail aadress. Additional information: +372 631 4111